Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 3-12, February 2009

What have we learnt from early rheumatoid arthritis cohorts?

  • Adam Young, MD (Consultant Rheumatologist)

      Affiliations

    • Corresponding Author InformationTel.: +44 1727 897362; Fax: +44 01727 897042.

City Hospital, St Albans, Herts AL3 5PN, UK

Longitudinal and observational studies have provided valuable information on the course, clinical outcomes, and prognostic markers in rheumatoid arthritis (RA). They reflect a complete spectrum of disease in ‘true-to-life’ settings, and can identify aspects of RA such as long-term outcomes and predictive markers which are not easily obtained from clinical trials. Profiles of drug therapies gained over time from these studies complement those of short-term randomized studies. Comparisons of results from early-RA cohorts show both similarities and considerable differences.

Keywords: rheumatoid arthritis, longitudinal observational studies, inception cohorts, outcomes, prognostic factors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(08)00156-3

doi:10.1016/j.berh.2008.12.005

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 3-12, February 2009

Article Tools